GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)
INR 79.0
(-2.71%)
INR 79.0
(-2.71%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 375 Thousand INR | -92.93% |
| 2022 | 5.3 Million INR | 402.99% |
| 2021 | 1.05 Million INR | -73.73% |
| 2020 | 4.01 Million INR | -16.16% |
| 2019 | 4.78 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 277.44 Thousand INR | -73.11% |
| 2023 Q3 | 172.43 Thousand INR | -61.09% |
| 2023 Q1 | 317.39 Thousand INR | -41.72% |
| 2023 Q4 | 446.33 Thousand INR | 158.84% |
| 2023 FY | 1.49 Million INR | -71.72% |
| 2023 Q2 | 443.11 Thousand INR | 39.61% |
| 2022 Q2 | 409.64 Thousand INR | 0.0% |
| 2022 FY | 5.3 Million INR | 402.99% |
| 2022 Q3 | 9.23 Million INR | 2155.13% |
| 2022 Q4 | 544.56 Thousand INR | -94.11% |
| 2021 FY | 1.05 Million INR | -73.73% |
| 2020 FY | 4.01 Million INR | -16.16% |
| 2019 FY | 4.78 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.24 Million INR | 69.758% |
| Biocon Limited | 40.9 Billion INR | 99.999% |
| Blue Jet Healthcare Limited | 531.85 Million INR | 99.929% |
| Concord Biotech Limited | 1.45 Billion INR | 99.974% |
| Dishman Carbogen Amcis Limited | 5.14 Billion INR | 99.993% |
| FERMENTA BIOTECH LIMITED | 754.2 Million INR | 99.95% |
| Lyka Labs Limited | 599.4 Million INR | 99.937% |
| Panacea Biotec Limited | 1.99 Billion INR | 99.981% |
| SAMSRITA LABS LIMITED | 1.49 Million INR | 74.956% |
| Servoteach Industries Limited | 785.00 INR | -47670.701% |
| SMS Lifesciences India Limited | 602.96 Million INR | 99.938% |
| Supriya Lifescience Limited | 1.08 Billion INR | 99.965% |
| Syngene International Limited | 5.99 Billion INR | 99.994% |
| TAKE Solutions Limited | 396.91 Million INR | 99.906% |
| Titan Biotech Limited | 117.05 Million INR | 99.68% |
| Transgene Biotek Limited | 5.39 Million INR | 93.052% |
| Vanta Bioscience Limited | 38.95 Million INR | 99.037% |